【White】February 2026 Revenue: NT$0.09 Billion (YoY +5.0%)
NQ Score
53/100
N1 Content Completeness
4
AI Summary (NQ-processed)
White (4108), a biomedical company focused on new drug development, announced its revenue for February 2026. The company's monthly revenue was NT$0.09 billion, representing a 5.0% increase compared to the same period last year. This steady growth reflects the stable sales performance of its products in the market, including "White Blood Treasure."
AI analysis data is not yet available.